{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:29:50Z","timestamp":1772166590622,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Sciences Research Grants for Research on Human Genome and Gene Therapy from the Ministry of Health, Labor and Welfare of Japan","award":["21A-3"],"award-info":[{"award-number":["21A-3"]}]},{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology","award":["22390284"],"award-info":[{"award-number":["22390284"]}]},{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology","award":["22-40134"],"award-info":[{"award-number":["22-40134"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Duchenne muscular dystrophy (DMD) is an inherited progressive disorder that causes skeletal and cardiac muscle deterioration with chronic inflammation. Dental pulp stem cells (DPSCs) are attractive candidates for cell-based strategies for DMD because of their immunosuppressive properties. Therefore, we hypothesized that systemic treatment with DPSCs might show therapeutic benefits as an anti-inflammatory therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To investigate the potential benefits of DPSC transplantation for DMD, we examined disease progression in a DMD animal model,\n                      <jats:italic>mdx<\/jats:italic>\n                      mice, by comparing them with different systemic treatment conditions. The DPSC-treated model, a canine X-linked muscular dystrophy model in Japan (CXMD\n                      <jats:sub>J<\/jats:sub>\n                      ), which has a severe phenotype similar to that of DMD patients, also underwent comprehensive analysis, including histopathological findings, muscle function, and locomotor activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We demonstrated a therapeutic strategy for long-term functional recovery in DMD using repeated DPSC administration. DPSC-treated\n                      <jats:italic>mdx<\/jats:italic>\n                      mice and CXMD\n                      <jats:sub>J<\/jats:sub>\n                      showed no serious adverse events. MRI findings and muscle histology suggested that DPSC treatment downregulated severe inflammation in DMD muscles and demonstrated a milder phenotype after DPSC treatment. DPSC-treated models showed increased recovery in grip-hand strength and improved tetanic force and home cage activity. Interestingly, maintenance of long-term running capability and stabilized cardiac function was also observed in 1-year-old DPSC-treated CXMD\n                      <jats:sub>J<\/jats:sub>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We developed a novel strategy for the safe and effective transplantation of DPSCs for DMD recovery, which included repeated systemic injection to regulate inflammation at a young age. This is the first report on the efficacy of a systemic DPSC treatment, from which we can propose that DPSCs may play an important role in delaying the DMD disease phenotype.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-02099-3","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T06:06:46Z","timestamp":1611554806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy"],"prefix":"10.1186","volume":"12","author":[{"given":"Yuko","family":"Nitahara-Kasahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuki","family":"Kuraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Posadas Herrera","family":"Guillermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Hayashita-Kinoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Maruoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Nakamura-Takahasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin\u2019ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2910-3797","authenticated-orcid":false,"given":"Takashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"2099_CR1","doi-asserted-by":"publisher","first-page":"15000","DOI":"10.1073\/pnas.192571199","volume":"99","author":"JN Haslett","year":"2002","unstructured":"Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A. 2002;99:15000\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2099_CR2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0092-8674(95)90344-5","volume":"80","author":"KP Campbell","year":"1995","unstructured":"Campbell KP. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell. 1995;80:675\u20139.","journal-title":"Cell."},{"key":"2099_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/345315a0","volume":"345","author":"JM Ervasti","year":"1990","unstructured":"Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 1990;345:315\u20139.","journal-title":"Nature."},{"key":"2099_CR4","doi-asserted-by":"crossref","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY.\u00a0Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016;13:CD003725.","DOI":"10.1002\/14651858.CD003725.pub4"},{"key":"2099_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677\u201386.","journal-title":"Trends Immunol"},{"key":"2099_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1212\/01.WNL.0000148485.00049.B7","volume":"64","author":"RT Moxley 3rd","year":"2005","unstructured":"Moxley RT 3rd, Ashwal S, Pandya S, Connolly A, Florence J, Mathews K, Baumbach L, McDonald C, Sussman M, Wade C. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2005;64:13\u201320.","journal-title":"Neurology."},{"key":"2099_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","volume":"6","author":"AJ Friedenstein","year":"1968","unstructured":"Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230\u201347.","journal-title":"Transplantation."},{"key":"2099_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jcp.21210","volume":"214","author":"AC Zannettino","year":"2008","unstructured":"Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, Gronthos S. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol. 2008;214:413\u201321.","journal-title":"J Cell Physiol"},{"key":"2099_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1634\/stemcells.2006-0335","volume":"25","author":"Q He","year":"2007","unstructured":"He Q, Wan C, Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells. 2007;25:69\u201377.","journal-title":"Stem Cells"},{"key":"2099_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cellimm.2008.04.003","volume":"251","author":"W Oh","year":"2008","unstructured":"Oh W, Kim DS, Yang YS, Lee JK. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol. 2008;251:116\u201323.","journal-title":"Cell Immunol"},{"key":"2099_CR11","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/humrep\/deh279","volume":"19","author":"MS Tsai","year":"2004","unstructured":"Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004;19:1450\u20136.","journal-title":"Hum Reprod"},{"key":"2099_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/term.71","volume":"2","author":"W Zhang","year":"2008","unstructured":"Zhang W, Walboomers XF, Van Kuppevelt TH, Daamen WF, Van Damme PA, Bian Z, Jansen JA. In vivo evaluation of human dental pulp stem cells differentiated towards multiple lineages. J Tissue Eng Regen Med. 2008;2:117\u201325.","journal-title":"J Tissue Eng Regen Med"},{"key":"2099_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1089\/ten.2006.0192","volume":"13","author":"YY Jo","year":"2007","unstructured":"Jo YY, Lee HJ, Kook SY, Choung HW, Park JY, Chung JH, Choung YH, Kim ES, Yang HC, Choung PH. Isolation and characterization of postnatal stem cells from human dental tissues. Tissue Eng. 2007;13:767\u201373.","journal-title":"Tissue Eng"},{"key":"2099_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cellimm.2016.08.008","volume":"310","author":"AT Ozdemir","year":"2016","unstructured":"Ozdemir AT, Ozgul Ozdemir RB, Kirmaz C, Sariboyaci AE, Unal Halbutogllari ZS, Ozel C, Karaoz E. The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets. Cell Immunol. 2016;310:108\u201315.","journal-title":"Cell Immunol"},{"key":"2099_CR15","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/nm963","volume":"9","author":"FD Camargo","year":"2003","unstructured":"Camargo FD, Green R, Capetanaki Y, Jackson KA, Goodell MA. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med. 2003;9:1520\u20137.","journal-title":"Nat Med"},{"key":"2099_CR16","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1097\/01.TP.0000137936.75203.B4","volume":"78","author":"TF Lee-Pullen","year":"2004","unstructured":"Lee-Pullen TF, Bennett AL, Beilharz MW, Grounds MD, Sammels LM. Superior survival and proliferation after transplantation of myoblasts obtained from adult mice compared with neonatal mice. Transplantation. 2004;78:1172\u20136.","journal-title":"Transplantation."},{"key":"2099_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.gt.3302887","volume":"14","author":"SP Quenneville","year":"2007","unstructured":"Quenneville SP, Chapdelaine P, Rousseau J, Tremblay JP. Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase. Gene Ther. 2007;14:514\u201322.","journal-title":"Gene Ther"},{"key":"2099_CR18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nature05282","volume":"444","author":"M Sampaolesi","year":"2006","unstructured":"Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, Innocenzi A, Mognol P, Thibaud JL, Galvez BG, Barthelemy I, Perani L, Mantero S, Guttinger M, Pansarasa O, Rinaldi C, Cusella De Angelis MG, Torrente Y, Bordignon C, Bottinelli R, Cossu G. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature. 2006;444:574\u20139.","journal-title":"Nature."},{"key":"2099_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ajmg.1320420320","volume":"42","author":"BA Valentine","year":"1992","unstructured":"Valentine BA, Winand NJ, Pradhan D, Moise NS, de Lahunta A, Kornegay JN, Cooper BJ. Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review. Am J Med Genet. 1992;42:352\u20136.","journal-title":"Am J Med Genet"},{"key":"2099_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/mt.2011.181","volume":"20","author":"Y Nitahara-Kasahara","year":"2012","unstructured":"Nitahara-Kasahara Y, Hayashita-Kinoh H, Ohshima-Hosoyama S, Okada H, Wada-Maeda M, Nakamura A, Okada T, Takeda S. Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy. Mol Ther. 2012;20:168\u201377.","journal-title":"Mol Ther"},{"key":"2099_CR21","first-page":"145","volume":"24","author":"Y Shimatsu","year":"2005","unstructured":"Shimatsu Y, Yoshimura M, Yuasa K, Urasawa N, Tomohiro M, Nakura M, Tanigawa M, Nakamura A, Takeda S. Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan. CXMDJ Acta Myol. 2005;24:145\u201354.","journal-title":"CXMDJ Acta Myol"},{"key":"2099_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2261-6-47","volume":"6","author":"N Yugeta","year":"2006","unstructured":"Yugeta N, Urasawa N, Fujii Y, Yoshimura M, Yuasa K, Wada MR, Nakura M, Shimatsu Y, Tomohiro M, Takahashi A, Machida N, Wakao Y, Nakamura A, Takeda S. Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies. BMC Cardiovasc Disord. 2006;6:47.","journal-title":"BMC Cardiovasc Disord"},{"key":"2099_CR23","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.107.739326","volume":"117","author":"N Urasawa","year":"2008","unstructured":"Urasawa N, Wada MR, Machida N, Yuasa K, Shimatsu Y, Wakao Y, Yuasa S, Sano T, Nonaka I, Nakamura A, Takeda S. Selective vacuolar degeneration in dystrophin-deficient canine Purkinje fibers despite preservation of dystrophin-associated proteins with overexpression of Dp71. Circulation. 2008;117:2437\u201348.","journal-title":"Circulation."},{"key":"2099_CR24","doi-asserted-by":"crossref","unstructured":"Aartsma-Rus A, van Putten M. Assessing functional performance in the mdx mouse model. J Vis Exp. 2014;85:e51303.","DOI":"10.3791\/51303"},{"key":"2099_CR25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.ajpath.2016.12.019","volume":"187","author":"J Hyzewicz","year":"2017","unstructured":"Hyzewicz J, Tanihata J, Kuraoka M, Nitahara-Kasahara Y, Beylier T, Ruegg UT, Vater A, Takeda S. Low-intensity training and the C5a complement antagonist NOX-D21 rescue the mdx phenotype through modulation of inflammation. Am J Pathol. 2017;187:1147\u201361.","journal-title":"Am J Pathol"},{"key":"2099_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.freeradbiomed.2015.01.023","volume":"82","author":"J Hyzewicz","year":"2015","unstructured":"Hyzewicz J, Tanihata J, Kuraoka M, Ito N, Miyagoe-Suzuki Y, Takeda S. Low intensity training of mdx mice reduces carbonylation and increases expression levels of proteins involved in energy metabolism and muscle contraction. Free Radic Biol Med. 2015;82:122\u201336.","journal-title":"Free Radic Biol Med"},{"key":"2099_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/eurheartj\/ehn406","volume":"30","author":"GM Buyse","year":"2009","unstructured":"Buyse GM, Van der Mieren G, Erb M, D'Hooge J, Herijgers P, Verbeken E, Jara A, Van Den Bergh A, Mertens L, Courdier-Fruh I, Barzaghi P, Meier T. Long-term blinded placebo-controlled study of SNT-MC17\/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. Eur Heart J. 2009;30:116\u201324.","journal-title":"Eur Heart J"},{"key":"2099_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/mt.2015.5","volume":"23","author":"H Hayashita-Kinoh","year":"2015","unstructured":"Hayashita-Kinoh H, Yugeta N, Okada H, Nitahara-Kasahara Y, Chiyo T, Okada T, Takeda S. Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance. Mol Ther. 2015;23:627\u201337.","journal-title":"Mol Ther"},{"key":"2099_CR29","doi-asserted-by":"publisher","first-page":"e0208415","DOI":"10.1371\/journal.pone.0208415","volume":"13","author":"M Kuraoka","year":"2018","unstructured":"Kuraoka M, Nitahara-Kasahara Y, Tachimori H, Kato N, Shibasaki H, Shin A, Aoki Y, Kimura E, Takeda S. Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs. Plos One. 2018;13:e0208415.","journal-title":"Plos One"},{"key":"2099_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1475-925X-13-156","volume":"13","author":"A Galan-Mercant","year":"2014","unstructured":"Galan-Mercant A, Baron-Lopez FJ, Labajos-Manzanares MT, Cuesta-Vargas AI. Reliability and criterion-related validity with a smartphone used in timed-up-and-go test. Biomed Eng Online. 2014;13:156.","journal-title":"Biomed Eng Online"},{"key":"2099_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2474-12-75","volume":"12","author":"I Barthelemy","year":"2011","unstructured":"Barthelemy I, Barrey E, Aguilar P, Uriarte A, Le Chevoir M, Thibaud JL, Voit T, Blot S, Hogrel JY. Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs. BMC Musculoskelet Disord. 2011;12:75.","journal-title":"BMC Musculoskelet Disord"},{"key":"2099_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/mus.21384","volume":"40","author":"M Kobayashi","year":"2009","unstructured":"Kobayashi M, Nakamura A, Hasegawa D, Fujita M, Orima H, Takeda S. Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging. Muscle Nerve. 2009;40:815\u201326.","journal-title":"Muscle Nerve"},{"key":"2099_CR33","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/apmr.2002.35109","volume":"83","author":"MK Childers","year":"2002","unstructured":"Childers MK, Okamura CS, Bogan DJ, Bogan JR, Petroski GF, McDonald K, Kornegay JN. Eccentric contraction injury in dystrophic canine muscle. Arch Phys Med Rehabil. 2002;83:1572\u20138.","journal-title":"Arch Phys Med Rehabil"},{"key":"2099_CR34","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1093\/hmg\/ddu113","volume":"23","author":"Y Nitahara-Kasahara","year":"2014","unstructured":"Nitahara-Kasahara Y, Hayashita-Kinoh H, Chiyo T, Nishiyama A, Okada H, Takeda S, Okada T. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10. Hum Mol Genet. 2014;23:3990\u20134000.","journal-title":"Hum Mol Genet"},{"key":"2099_CR35","doi-asserted-by":"publisher","first-page":"R983","DOI":"10.1152\/ajpregu.00375.2007","volume":"294","author":"N Stupka","year":"2008","unstructured":"Stupka N, Schertzer JD, Bassel-Duby R, Olson EN, Lynch GS. Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice. Am J Physiol Regul Integr Comp Physiol. 2008;294:R983\u201392.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2099_CR36","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.ajpath.2011.07.022","volume":"179","author":"K Rouger","year":"2011","unstructured":"Rouger K, Larcher T, Dubreil L, Deschamps JY, Le Guiner C, Jouvion G, Delorme B, Lieubeau B, Carlus M, Fornasari B, Theret M, Orlando P, Ledevin M, Zuber C, Leroux I, Deleau S, Guigand L, Testault I, Le Rumeur E, Fiszman M, Cherel Y. Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs. Am J Pathol. 2011;179:2501\u201318.","journal-title":"Am J Pathol"},{"key":"2099_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1538\/expanim.52.93","volume":"52","author":"Y Shimatsu","year":"2003","unstructured":"Shimatsu Y, Katagiri K, Furuta T, Nakura M, Tanioka Y, Yuasa K, Tomohiro M, Kornegay JN, Nonaka I, Takeda S. Canine X-linked muscular dystrophy in Japan (CXMDJ). Exp Anim. 2003;52:93\u20137.","journal-title":"Exp Anim"},{"key":"2099_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2261-11-23","volume":"11","author":"H Takano","year":"2011","unstructured":"Takano H, Fujii Y, Yugeta N, Takeda S, Wakao Y. Assessment of left ventricular regional function in affected and carrier dogs with Duchenne muscular dystrophy using speckle tracking echocardiography. BMC Cardiovasc Disord. 2011;11:23\u201330.","journal-title":"BMC Cardiovasc Disord."},{"key":"2099_CR39","first-page":"891972","volume":"2015","author":"R Cruz-Guzman Odel","year":"2015","unstructured":"Cruz-Guzman Odel R, Rodriguez-Cruz M, Escobar Cedillo RE. Systemic inflammation in Duchenne muscular dystrophy: association with muscle function and nutritional status. Biomed Res Int. 2015;2015:891972.","journal-title":"Biomed Res Int"},{"key":"2099_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1479-5876-6-35","volume":"6","author":"I Kerkis","year":"2008","unstructured":"Kerkis I, Ambrosio CE, Kerkis A, Martins DS, Zucconi E, Fonseca SA, Cabral RM, Maranduba CM, Gaiad TP, Morini AC, Vieira NM, Brolio MP, Sant'Anna OA, Miglino MA, Zatz M. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: local or systemic? J Transl Med. 2008;6:35.","journal-title":"J Transl Med"},{"key":"2099_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13287-015-0141-y","volume":"6","author":"A Pisciotta","year":"2015","unstructured":"Pisciotta A, Riccio M, Carnevale G, Lu A, De Biasi S, Gibellini L, La Sala GB, Bruzzesi G, Ferrari A, Huard J, De Pol A. Stem cells isolated from human dental pulp and amniotic fluid improve skeletal muscle histopathology in mdx\/SCID mice. Stem Cell Res Ther. 2015;6:156.","journal-title":"Stem Cell Res Ther"},{"key":"2099_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41232-016-0019-0","volume":"36","author":"Y Nitahara-Kasahara","year":"2016","unstructured":"Nitahara-Kasahara Y, Takeda S, Okada T. Inflammatory predisposition predicts disease phenotypes in muscular dystrophy. Inflamm Regen. 2016;36:14.","journal-title":"Inflamm Regen"},{"key":"2099_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/BF00869001","volume":"243","author":"SC Jacobs","year":"1996","unstructured":"Jacobs SC, Bootsma AL, Willems PW, Bar PR, Wokke JH. Prednisone can protect against exercise-induced muscle damage. J Neurol. 1996;243:410\u20136.","journal-title":"J Neurol"},{"key":"2099_CR44","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/mus.23432","volume":"46","author":"F Serra","year":"2012","unstructured":"Serra F, Quarta M, Canato M, Toniolo L, De Arcangelis V, Trotta A, Spath L, Monaco L, Reggiani C, Naro F. Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs. Muscle Nerve. 2012;46:773\u201384.","journal-title":"Muscle Nerve"},{"key":"2099_CR45","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.nmd.2006.06.011","volume":"16","author":"S Hodgetts","year":"2006","unstructured":"Hodgetts S, Radley H, Davies M, Grounds MD. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice. Neuromuscul Disord. 2006;16:591\u2013602.","journal-title":"Neuromuscul Disord"},{"key":"2099_CR46","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0002-9440(10)65050-X","volume":"156","author":"B Cai","year":"2000","unstructured":"Cai B, Spencer MJ, Nakamura G, Tseng-Ong L, Tidball JG. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Am J Pathol. 2000;156:1789\u201396.","journal-title":"Am J Pathol"},{"key":"2099_CR47","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1096\/fj.03-1024com","volume":"18","author":"MD Grounds","year":"2004","unstructured":"Grounds MD, Torrisi J. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J. 2004;18:676\u201382.","journal-title":"FASEB J"},{"key":"2099_CR48","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/gt.2011.207","volume":"19","author":"Q Yang","year":"2012","unstructured":"Yang Q, Tang Y, Imbrogno K, Lu A, Proto JD, Chen A, Guo F, Fu FH, Huard J, Wang B. AAV-based shRNA silencing of NF-kappaB ameliorates muscle pathologies in mdx mice. Gene Ther. 2012;19:1196\u2013204.","journal-title":"Gene Ther"},{"key":"2099_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5507\/bp.2013.078","volume":"158","author":"P Stanko","year":"2014","unstructured":"Stanko P, Kaiserova K, Altanerova V, Altaner C. Comparison of human mesenchymal stem cells derived from dental pulp, bone marrow, adipose tissue, and umbilical cord tissue by gene expression. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158:373\u20137.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"2099_CR50","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/aps.2016.38","volume":"37","author":"YC Shang","year":"2016","unstructured":"Shang YC, Wang SH, Xiong F, Peng FN, Liu ZS, Geng J, Zhang C. Activation of Wnt3a signaling promotes myogenic differentiation of mesenchymal stem cells in mdx mice. Acta Pharmacol Sin. 2016;37:873\u201381.","journal-title":"Acta Pharmacol Sin"},{"key":"2099_CR51","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1038\/s41598-017-02928-1","volume":"7","author":"Y Maeda","year":"2017","unstructured":"Maeda Y, Yonemochi Y, Nakajyo Y, Hidaka H, Ikeda T, Ando Y. CXCL12 and osteopontin from bone marrow-derived mesenchymal stromal cells improve muscle regeneration. Sci Rep. 2017;7:3305.","journal-title":"Sci Rep"},{"key":"2099_CR52","first-page":"306","volume":"15","author":"YN Liu","year":"2007","unstructured":"Liu YN, Yan X, Sun Z, Han Q, Zhao RC. Mice adipose derived Flk-1+ mesenchymal stem cells can ameliorate Duchenne's muscular dystrophy in mdx mice for their multilineage potential. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007;15:306\u201312.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"2099_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biomaterials.2018.04.055","volume":"174","author":"A Bier","year":"2018","unstructured":"Bier A, Berenstein P, Kronfeld N, Morgoulis D, Ziv-Av A, Goldstein H, Kazimirsky G, Cazacu S, Meir R, Popovtzer R, Dori A, Brodie C. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy. Biomaterials. 2018;174:67\u201378.","journal-title":"Biomaterials."},{"key":"2099_CR54","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/cells8121491","volume":"8","author":"MDP De la Rosa-Ruiz","year":"2019","unstructured":"De la Rosa-Ruiz MDP, Alvarez-Perez MA, Cortes-Morales VA, Monroy-Garcia A, Mayani H, Fragoso-Gonzalez G, Caballero-Chacon S, Diaz D, Candanedo-Gonzalez F, Montesinos JJ. Mesenchymal stem\/stromal cells derived from dental tissues: a comparative in vitro evaluation of their immunoregulatory properties against T cells. Cells. 2019;8:1491\u2013512.","journal-title":"Cells."},{"key":"2099_CR55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4103\/1305-7456.137631","volume":"8","author":"D Ponnaiyan","year":"2014","unstructured":"Ponnaiyan D, Jegadeesan V. Comparison of phenotype and differentiation marker gene expression profiles in human dental pulp and bone marrow mesenchymal stem cells. Eur J Dent. 2014;8:307\u201313.","journal-title":"Eur J Dent"},{"key":"2099_CR56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13287-017-0705-0","volume":"8","author":"A Bakopoulou","year":"2017","unstructured":"Bakopoulou A, Apatzidou D, Aggelidou E, Gousopoulou E, Leyhausen G, Volk J, Kritis A, Koidis P, Geurtsen W. Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects \u201cstemness\u201d properties. Stem Cell Res Ther. 2017;8:247.","journal-title":"Stem Cell Res Ther"},{"key":"2099_CR57","doi-asserted-by":"publisher","first-page":"4709572","DOI":"10.1155\/2016\/4709572","volume":"2016","author":"E Ledesma-Martinez","year":"2016","unstructured":"Ledesma-Martinez E, Mendoza-Nunez VM, Santiago-Osorio E. Mesenchymal stem cells derived from dental pulp: a review. Stem Cells Int. 2016;2016:4709572.","journal-title":"Stem Cells Int"},{"key":"2099_CR58","doi-asserted-by":"publisher","first-page":"e34608","DOI":"10.1371\/journal.pone.0034608","volume":"7","author":"H Liu","year":"2012","unstructured":"Liu H, Liu S, Li Y, Wang X, Xue W, Ge G, Luo X. The role of SDF-1-CXCR4\/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia\/reperfusion injury. Plos One. 2012;7:e34608.","journal-title":"Plos One"},{"key":"2099_CR59","first-page":"80","volume":"122","author":"K Sakai","year":"2012","unstructured":"Sakai K, Yamamoto A, Matsubara K, Nakamura S, Naruse M, Yamagata M, Sakamoto K, Tauchi R, Wakao N, Imagama S, Hibi H, Kadomatsu K, Ishiguro N, Ueda M. Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J Clin Invest. 2012;122:80\u201390.","journal-title":"J Clin Invest"},{"key":"2099_CR60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.scr.2015.02.003","volume":"14","author":"B Mead","year":"2015","unstructured":"Mead B, Berry M, Logan A, Scott RA, Leadbeater W, Scheven BA. Stem cell treatment of degenerative eye disease. Stem Cell Res. 2015;14:243\u201357.","journal-title":"Stem Cell Res"},{"key":"2099_CR61","first-page":"57","volume":"9","author":"E Sun","year":"2020","unstructured":"Sun E, Karaoz E. Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect. Am J Stem Cells. 2020;9:57\u201367.","journal-title":"Am J Stem Cells"},{"key":"2099_CR62","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/0022034509340867","volume":"88","author":"GT Huang","year":"2009","unstructured":"Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res. 2009;88:792\u2013806.","journal-title":"J Dent Res"},{"key":"2099_CR63","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3390\/ijms20051132","volume":"20","author":"Y Yamada","year":"2019","unstructured":"Yamada Y, Nakamura-Yamada S, Kusano K, Baba S. Clinical potential and current progress of dental pulp stem cells for various systemic diseases in regenerative medicine: a concise review. Int J Mol Sci. 2019;20:1132\u201348.","journal-title":"Int J Mol Sci."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-02099-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-02099-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-02099-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T06:18:50Z","timestamp":1611555530000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-02099-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2099"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-02099-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-94158\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"13 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments using MSCs were conducted in accordance with the protocol approved by the Institutional Animal Care and Use Committee of Nippon Medical School (27-199) and National Center of Neurology and Psychiatry (NCNP) Animal Ethics Committees (2012011, 2015004, and 19\u201330-06).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Y. N-K., H. H-K., and T. O. were members of the Division of Cell and Gene Therapy, Nippon Medical School, which is an endowment department, supported with an unrestricted grant from JCR Pharmaceuticals Co., Ltd., and Kaneka Corporation. hDPSCs were provided by JCR Pharmaceuticals Co., Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}